Terumo (TRUMY) Short Interest Ratio & Short Volume → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free TRUMY Stock Alerts $17.59 +0.44 (+2.56%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Terumo Short Interest DataCurrent Short Volume2,700 sharesPrevious Short Volume3,800 sharesChange Vs. Previous Month-28.95%Dollar Volume Sold Short$45,684.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares1,490,700,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume29,291 sharesAverage Trading Volume61,799 sharesToday's Volume Vs. Average47% Short Selling Terumo ? Sign up to receive the latest short interest report for Terumo and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTRUMY Short Interest Over TimeTRUMY Days to Cover Over TimeTRUMY Percentage of Float Shorted Over Time Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development Terumo Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,700 shares $45,684.00 -29.0%N/A0 $16.92 4/15/20243,800 shares $62,814.00 +46.2%N/A0 $16.53 3/31/20242,600 shares $95,615.00 +271.4%N/A0.1 $36.78 3/15/2024700 shares $26,796.00 -76.7%N/A0 $38.28 2/29/20243,000 shares $116,520.00 +233.3%N/A0.1 $38.84 2/15/2024900 shares $33,480.00 -88.5%N/A0 $37.20 Get the Latest News and Ratings for TRUMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,900 shares $66,443.00 -24.0%N/A0 $34.97 12/31/20232,500 shares $81,550.00 -85.2%N/A0.1 $32.62 12/15/202316,900 shares $548,574.00 +704.8%N/A0.3 $32.46 11/30/20232,100 shares $67,053.00 -60.4%N/A0 $31.93 11/15/20235,300 shares $164,671.00 -27.4%N/A0.1 $31.07 10/31/20237,300 shares $199,655.00 +121.2%N/A0 $27.35 10/15/20233,300 shares $82,978.50 -83.7%N/A0 $25.15 9/30/202320,200 shares $535,603.00 +461.1%N/A0.2 $26.52 9/15/20233,600 shares $106,074.00 -64.4%N/A0 $29.47 8/31/202310,100 shares $305,020.00 -68.7%N/A0.2 $30.20 8/15/202332,300 shares $945,744.00 +100.6%N/A0.3 $29.28 7/31/202316,100 shares $525,504.00 -14.8%N/A0.5 $32.64 7/15/202318,900 shares $594,027.00 -30.3%N/A0.4 $31.43 6/30/202327,100 shares $863,135.00 +95.0%N/A0.4 $31.85 6/15/202313,900 shares $455,503.00 +44.8%N/A0.3 $32.77 5/31/20239,600 shares $291,288.00 -8.6%N/A0.3 $30.34 5/15/202310,500 shares $327,285.00 -38.2%N/A0.3 $31.17 4/30/202317,000 shares $509,150.00 +53.2%N/A0.1 $29.95 4/15/202311,100 shares $319,125.00 +208.3%N/A0.1 $28.75 3/31/20233,600 shares $97,128.00 -29.4%N/A0 $26.98 3/15/20235,100 shares $133,620.00 -77.7%N/A0 $26.20 2/28/202322,900 shares $617,613.00 +87.7%N/A0.2 $26.97 2/15/202312,200 shares $346,602.00 +45.2%N/A0.2 $28.41 1/31/20238,400 shares $243,852.00 +460.0%N/A0.1 $29.03 1/15/20231,500 shares $41,370.00 -93.2%N/A0 $27.58 12/30/202222,100 shares $622,888.50 +750.0%N/A0.2 $28.19 12/15/20222,600 shares $75,972.00 -82.8%N/A0 $29.22 11/30/202215,100 shares $445,752.00 +32.5%N/A0.1 $29.52 11/15/202211,400 shares $329,460.00 +75.4%N/A0.1 $28.90 10/31/20226,500 shares $197,015.00 +3,150.0%N/A0.1 $30.31 10/15/2022200 shares $5,808.00 +100.0%N/A0 $29.04 9/30/2022100 shares $2,810.00 -98.7%N/A0 $28.10 9/15/20227,400 shares $226,440.00 -66.5%N/A0.1 $30.60 8/31/202222,100 shares $710,515.00 +16.9%N/A0.3 $32.15The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development TRUMY Short Interest - Frequently Asked Questions What is Terumo's current short interest? Short interest is the volume of Terumo shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,700 shares of TRUMY short. Learn More on Terumo's current short interest. Is Terumo's short interest increasing or decreasing? Terumo saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 2,700 shares, a decline of 28.9% from the previous total of 3,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Terumo's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Terumo: Henry Schein, Inc. (3.98%), West Pharmaceutical Services, Inc. (1.44%), ICON Public Limited (2.34%), Koninklijke Philips (0.48%), Zimmer Biomet Holdings, Inc. (2.08%), Cardinal Health, Inc. (3.51%), STERIS plc (2.41%), Merck KGaA (0.53%), BioNTech SE (1.55%), Waters Co. (6.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Terumo stock? Short selling TRUMY is an investing strategy that aims to generate trading profit from Terumo as its price is falling. TRUMY shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Terumo? A short squeeze for Terumo occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRUMY, which in turn drives the price of the stock up even further. How often is Terumo's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRUMY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Henry Schein Short Squeeze West Pharmaceutical Services Short Squeeze ICON Public Short Squeeze Koninklijke Philips Short Squeeze Coloplast A/S Short Squeeze Zimmer Biomet Short Squeeze Cardinal Health Short Squeeze STERIS Short Squeeze Merck KGaA Short Squeeze BioNTech Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:TRUMY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts